Lexaria Bioscience Corp. financial data

Symbol
LEXX, LEXXW on Nasdaq
Industry
Pharmaceutical Preparations
Location
100 740 Mccurdy Road, Kelowna, British Columbia, Canada
State of incorporation
NV
Fiscal year end
August 31
Former names
Lexaria Corp. (to 5/11/2016), LEXARIA CORP. (to 5/11/2016)
Latest financial report
10-Q - Q1 2025 - Apr 14, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 994 % +4.86%
Quick Ratio 0.96 % -94.4%
Debt-to-equity 10.8 % -7.05%
Return On Equity -112 % +16.5%
Return On Assets -100 % +15.5%
Operating Margin -1.79K % -35.7%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 17.6M shares +36.3%
Common Stock, Shares, Outstanding 17.4M shares +40.9%
Entity Public Float 40.6M USD
Common Stock, Value, Issued 17.6K USD +41.7%
Weighted Average Number of Shares Outstanding, Diluted 17.5M shares +62.7%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 526K USD +29.9%
Revenue from Contract with Customer, Excluding Assessed Tax 184K USD +21.6%
Research and Development Expense 5.18M USD +74.9%
General and Administrative Expense 4.73M USD +72.2%
Operating Income (Loss) -9.39M USD -76.4%
Nonoperating Income (Expense) 34K USD +123%
Net Income (Loss) Attributable to Parent -9.38M USD -72.5%
Earnings Per Share, Diluted -0.15 USD/shares -150%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 6.5M USD
Marketable Securities, Current 73.9K USD -15.7%
Accounts Receivable, after Allowance for Credit Loss, Current 331K USD -7.26%
Inventory, Net 0 USD -100%
Assets, Current 7.72M USD +42.6%
Property, Plant and Equipment, Net 262K USD +15.7%
Operating Lease, Right-of-Use Asset 157K USD +4.5%
Assets 8.68M USD +36.6%
Liabilities, Current 1.82M USD +2130%
Operating Lease, Liability, Noncurrent 94.4K USD
Liabilities 1.92M USD +839%
Accumulated Other Comprehensive Income (Loss), Net of Tax -118K USD -473%
Retained Earnings (Accumulated Deficit) -57M USD -19.7%
Stockholders' Equity Attributable to Parent 7.14M USD +9.57%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 6.76M USD +9.97%
Liabilities and Equity 8.68M USD +36.6%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -2.73M USD -131%
Net Cash Provided by (Used in) Financing Activities 4.35M USD +139%
Net Cash Provided by (Used in) Investing Activities -37.8K USD +5.55%
Common Stock, Shares Authorized 220M shares 0%
Common Stock, Shares, Issued 17.6M shares +41.7%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 1.58M USD +162%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 6.47M USD +37.5%
Deferred Tax Assets, Valuation Allowance 10.7M USD +12%
Deferred Tax Assets, Gross 10.7M USD +12%
Operating Lease, Liability 124K USD -16.9%
Payments to Acquire Property, Plant, and Equipment 24.6K USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -9.48M USD -73.6%
Lessee, Operating Lease, Liability, to be Paid 142K USD -19.7%
Property, Plant and Equipment, Gross 772K USD
Operating Lease, Liability, Current 29.3K USD
Lessee, Operating Lease, Liability, to be Paid, Year Two 38.6K USD +4.17%
Lessee, Operating Lease, Liability, to be Paid, Year One 37.3K USD +108%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure 0%
Lessee, Operating Lease, Liability, to be Paid, Year Three 38.9K USD +4.17%
Lessee, Operating Lease, Liability, to be Paid, Year Four 8.1K USD -79%
Operating Lease, Payments 8.96K USD -80%
Additional Paid in Capital 64.2M USD +18.7%
Depreciation, Depletion and Amortization 8.73K USD
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Share-based Payment Arrangement, Expense 99.4K USD +84.3%